Watch to learn about the Flex Study, a study to evaluate the safety and efficacy of an investigational medication on reducing symptoms of adults with Dermatomyositis.
Joining MSU from Alexion Pharmaceuticals - Christine Rowe, Director of Patient Advocacy, and Sanjay Rakhade MD, Ph.D., Executive Medical Director at Alexion Astra Zeneca Rare Disease Unit in Boston, MA.
View more details and find study information at https://understandingmyositis.org/clinical-study-dermatomyositis/